Antiparasitic Prodrug Nifurtimox: Revisiting its Activation Mechanism

10.1074/jbc.M111.230847

10.1097/MPH.0b013e3181f47061

PackchanianA. Chemotherapy of experimental Chagas disease with nitrofuran compounds. J. Parasitol. 38(30) , 30–40 (1952).

10.1016/0003-9861(79)90251-0

10.1016/0006-2952(81)90204-5

AldunateJ, MorelloA. Free radicals in the mode of action of antiparasitic drugs. In: Free Radicals in Tropical Diseases. Aruoma OI (Ed.). Harwood Academic Publishers, London, UK, 137–165 (1993).

10.1016/j.bcp.2010.02.009

10.1084/jem.20020885

10.1073/pnas.0711014105

10.1093/jac/dkn222

FerreiraRC, FerreiraLC. Mutagenicity of nifurtimox and benznidazole in the Salmonella/microsome assay. Braz. J. Med. Biol. Res. 19(1) , 19–25 (1986).

10.1016/0165-1218(88)90160-7

10.1016/j.toxlet.2009.07.006

10.1002/em.2850260113

Herlinger H Mayer KH Petersen S Bock M: WO1170957 (1964).

TDR research. Chagas disease http://apps.who.int/tdr/svc/diseases/chagas

TDRnews. TDR explores shorter HAT treatment options. March 2009 http://apps.who.int/tdr/svc/publications/tdrnews/issue-82/hat-treatment